miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes

Background. The use of miRNAs as biomarkers for Type 1 Diabetes (T1D) risk is attractive as T1D is usually diagnosed in front of acute symptoms. As miR-375 is highly expressed in the endocrine pancreas, we postulated that its circulating level might reflect beta cell alterations and might be altered...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Diabetes Research Jg. 2016; H. 2016; S. 1 - 7
Hauptverfasser:	Rome, Sophie, Thivolet, Charles, Nicolino, Marc, Fabien, Nicole, Van den Hende, Kathleen, Meugnier, Emmanuelle, Jalabert, Audrey, Marchand, Lucien, Madec, Anne-Marie
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Cairo, Egypt Hindawi Publishing Corporation 01.01.2016 John Wiley & Sons, Inc Hindawi Publishing Coporation Wiley
Schlagworte:	Adolescent Age Autoantibodies Autoimmunity Biomarkers Child Dextrose Diabetes Diabetes Mellitus, Type 1 - blood Diabetes therapy Disease Down-Regulation - drug effects Female Gender Gene expression Glucose Glucose - pharmacology Glycosylated hemoglobin Humans Insulin Islets of Langerhans - drug effects Islets of Langerhans - metabolism Life Sciences Male Metabolism MicroRNA MicroRNAs - blood Pancreas Pediatrics Sensors Software Type 1 diabetes Type 2 diabetes France micrornas disease nod mice autoimmune mir-375 biomarkers responses mechanism strategy beta-cell mass
ISSN:	2314-6745, 2314-6753, 2314-6753
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!